Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sino Biopharmaceutical Ltd.

0.9162
+0.03534.01%
Volume:1.64K
Turnover:1.50K
Market Cap:16.68B
PE:34.97
High:0.9162
Open:0.9162
Low:0.9162
Close:0.8809
Loading ...

Company Profile

Company Name:
Sino Biopharmaceutical Ltd.
Exchange:
PINK LIMITED
Establishment Date:
2000
Employees:
24379
Office Location:
Unit 09, Office Tower,41st Floor, Room 4109,Convention Plaza,1 Harbour Road,Wan Chai,Hong Kong
Zip Code:
- -
Fax:
- -
Introduction:
Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines comprising Qingkeshu tablets, Focus V capsules, Annike injection, and Anyue capsules; liver disease medicines, including Tianqing ganmei injection and Runzhong dispersible tablets; and respiratory system medicines, such as Tianqing suchang suspension for inhalation and Tianyun for injection. It also provides surgery/analgesia medicines comprising Debaian cataplasms and Gaisanchun soft capsules; and cardio-cerebral vascular medicines, including Yilunping and Kaina tablets. In addition, the company is involved in the long term investments; and healthcare and hospital business. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.